Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

eRXSYS' Application to the California Medicaid Program (Medi-Cal) is Approved

Posted on: Thursday, 8 September 2005, 06:00 CDT

IRVINE, Calif., Sept. 8 /PRNewswire-FirstCall/ -- eRXSYS, Inc. (BULLETIN BOARD: ERXI) . eRXSYS received notice on August 22, 2005 that its application to the California Medicaid Program (Medi-Cal) was approved. eRXSYS was assigned a unique provider identification number to enable its pharmacies to process claims through Medi-Cal. Medicaid is a federal and state program that provides health coverage, including prescription drug coverage to those that require financial assistance. eRXSYS anticipates that this approval and its ability to process claims through Medi-Cal will increase sales at its California pharmacy located in Riverside.

About eRXSYS, Inc.

eRXSYS is engaged in the business of operating pharmacies that specialize in dispensing highly regulated pain medication by utilizing technology that allows physicians to transmit prescriptions from a wireless hand-held device or desktop computer directly to its pharmacies, thus eliminating or reducing the need for paper prescriptions.

Certain statements in this news release may constitute "forward-looking" statements within the meaning of section 21E of the Securities and Exchange Act of 1934. The Company believes that its expectations, as expressed in these statements are based on reasonable assumptions regarding the risks and uncertainties inherent in achieving those expectations. These statements are not, however, guarantees of future performance and actual results may differ materially. Some of the factors that may affect the forward looking statements in this news release are the availability of licensed personnel to operate pharmacies, the availability of suitable pharmacy locations, and the acceptance of new technologies by the medical profession. Other risk factors are listed in the most recent Annual Report on Form 10-KSB, Quarterly Report on Form 10-QSB, and most recent Registration Statement on Form SB-2 filed with the Securities and Exchange Commission. Such forward-looking statements involve risks, uncertainties, which may cause the actual results, performance, or achievement expressed or implied to differ.

eRXSYS, Inc.

CONTACT: Robert DelVecchio, CEO of eRXSYS, Inc.,investorrelations@eRXSYS.com

Web site: http://www.erxsys.com/


Source: PRNewswire-FirstCall

More News in this Category


Related Articles



Rating: 3.3 / 5 (15 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required